Atlas Trials

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)

Clinical trial NCT05558644 · RECRUITING

Trial details

NCT number
NCT05558644
Sponsor
Institut Curie
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Cancer
Start date
2023-08-03
Primary completion
2028-10-02
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.